Related Experiment Videos
Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein
Immunology
|January 1, 1984
Summary
Human eosinophil degranulation involves C3 receptor interaction for releasing eosinophil cationic protein (ECP). Inhibitors like cytochalasin B and hydrocortisone directly affect degranulation, not cell adherence, suggesting distinct mechanisms from neutrophils.
Area of Science:
- Immunology
- Cell Biology
Background:
- Eosinophils are key immune cells involved in allergic responses and host defense.
- Understanding eosinophil degranulation mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the mechanisms of degranulation in human eosinophils.
- To identify factors influencing the release of eosinophil cationic protein (ECP).
Main Methods:
- Purified human eosinophils were exposed to serum-treated Sephadex beads to activate complement.
- Measurement of extracellular ECP release and eosinophil adherence to beads.
- Assessment of the effects of cytochalasins, hydrocortisone, ECF-A, histamine, and colchicine on degranulation and adherence.
Main Results:
- Approximately 15% of cellular ECP was released upon exposure to serum-treated Sephadex.
- Eosinophil adherence to serum-treated Sephadex was high, suggesting C3 receptor involvement in ECP release.
- Cytochalasin B, cytochalasin D, and hydrocortisone inhibited ECP release without affecting adherence, indicating a direct effect on degranulation.
- No direct correlation was found between degranulation and the oxidative burst.
Conclusions:
- C3 receptor interaction is a prerequisite for ECP release from eosinophils stimulated by serum-treated Sephadex.
- The degranulation process in eosinophils is directly inhibited by cytochalasins and hydrocortisone.
- Eosinophil degranulation mechanisms appear distinct from those in neutrophils.